Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

Clinical trial NCT02349841 · COMPLETED

Trial details

NCT number: NCT02349841
Sponsor: TASK Applied Science
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2014-09-01
Primary completion: 2014-12-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.